![ECOG-ACRIN logo[19516]275×75](https://blog.ecog-acrin.org/wp-content/uploads/2021/03/ECOG-ACRIN-logo19516275x75.png)
August 31, 2026
This phase 2 clinical trial is testing two variations of the triplet combination of azacitidine, venetoclax, and gilteritinib compared to standard therapy
August 31, 2026
Timely information about research presented at medical meetings, recognition of research leaders, and more
July 31, 2026
The latest findings in breast cancer, cardiotoxicity, leukemia, lung cancer, myeloma, NCI-MATCH, and smoking cessation support during cancer treatment
May 28, 2026
The latest findings in breast cancer, cardiotoxicity, leukemia in older adults, and reproductive health management for cancer patients of childbearing age
April 24, 2026
The latest clinical trial findings in breast cancer, cancer control and survivorship, health equity, leukemia, melanoma, and NCI-MATCH
March 30, 2026
The latest findings in breast cancer, cancer care delivery research, head and neck cancer, leukemia, and radiation therapy
February 27, 2026
The latest clinical trial findings in breast cancer, leukemia, lymphoma, lung cancer, NCI-MATCH, and prostate cancer
January 30, 2026
10 cancer research discoveries in 2025 by ECOG-ACRIN and PrECOG that captured attention across the scientific and patient advocacy communities
January 30, 2026
The latest research in breast cancer, geriatric oncology, leukemia, NCI-MATCH, and symptom management
December 19, 2025
Blood and breast cancer research highlights from the 67th American Society of Hematology Annual Meeting and Exposition, and the San Antonio Breast Cancer Symposium
November 21, 2025
Timely information about research presented at medical meetings, recognition of research leaders, and more
August 28, 2025
The latest clinical trial findings in breast cancer, leukemia, NCI-MATCH precision medicine, penile cancer, and prostate cancer